Hetero Biopharma at Kenya Renal Association (KRA)- 2018
Hetero Biopharma recently participated in Kenya Renal Association (KRA) conference - 2018, which is recognized to be a major annual knowledge platform in East Africa. This conference was organized for several leading nephrologists from east African countries namely Kenya, Uganda, Tanzania etc. The conference was scheduled from 27th – 30th Sept 2018. During this conference, Dr Ahmed Sokhwala, Asst. Professor & Consultant Nephrologist, Dept. – Nephrology, The Aga Khan University & Hospital – Nairobi (Kenya) addressed the audience as a Key Opinion Leader (KOL) on behalf of Hetero Biopharma. He presented a session on “Less frequent erythropoietic therapy: Darbepoetin alfa has a better advantage?” as well as highlighting the importance of DERISE (Darbepoetin Alfa) in the management of Anaemia associated with CKD.
Mr. Manish Soni (Country Manager – Kenya) emphasized on the overall vision of Hetero Biopharma. The session ended with vote of thanks by Mr. Manish Soni. Besides the session, our product portfolio has also been showcased by Hetero team, at the conference through our Hetero booth.